News Arch Therapeutics, Inc.

Equities

ARTH

US03939W2089

Market Closed - OTC Markets Other stock markets 03:40:47 2024-05-06 pm EDT			5-day change	1st Jan Change
0.95 ^USD	+2.70%		-19.49%	-86.88%

Feb. 20	Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Feb. 15	Arch Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)	May. 06	AQ
Arch Therapeutics : New Financial Obligation - Form 8-K	Apr. 03	PU
Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 20	CI
Arch Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Feb. 15	CI
Arch Therapeutics : New Financial Obligation - Form 8-K	Dec. 15	PU
Arch Therapeutics Provides Year End Operational Update	Nov. 09	AQ
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	Nov. 02	AQ
Arch Therapeutics, Inc. to Present AC5®? Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	Nov. 02	CI
Arch Therapeutics, Inc. Provides Commercialization Update on the First Product, AC5 Advanced Wound System	23-09-13	CI
Arch Therapeutics Provides AC5® Commercialization Update	23-09-13	AQ
Arch Therapeutics Completes Financing as Bridge to Uplisting	23-09-07	AQ
Arch Therapeutics, Inc. announced that it has received $2.560063 million in funding	23-08-30	CI
Arch Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-11	CI
Arch Therapeutics, Inc. announced that it expects to receive $1.850001 million in funding	23-07-06	CI
Arch Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-23	CI
Arch Therapeutics to Present AC5(R) Advanced Wound System At 2023 Symposium on Advanced Wound Care	23-04-25	CI
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)	23-04-25	AQ
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect	23-04-05	AQ
Arch Therapeutics, Inc. Announces Dedicated HCPCS Billing Code for its Advanced Wound System Now in Effect	23-04-05	CI
Arch Therapeutics : Material Agreement - Form 8-K	23-03-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arch Therapeutics, Inc.

Equities

ARTH

US03939W2089

Summary

Filters